Cargando…
Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L
Since the outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), public health worldwide has been greatly threatened. The development of an effective treatment for this infection is crucial and urgent but is hampered by the incompl...
Autores principales: | Yu, Fei, Pan, Ting, Huang, Feng, Ying, Ruosu, Liu, Jun, Fan, Huimin, Zhang, Junsong, Liu, Weiwei, Lin, Yingtong, Yuan, Yaochang, Yang, Tao, Li, Rong, Zhang, Xu, Lv, Xi, Chen, Qianyu, Liang, Anqi, Zou, Fan, Liu, Bingfeng, Hu, Fengyu, Tang, Xiaoping, Li, Linghua, Deng, Kai, He, Xin, Zhang, Hui, Zhang, Yiwen, Ma, Xiancai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096618/ https://www.ncbi.nlm.nih.gov/pubmed/35572668 http://dx.doi.org/10.3389/fmicb.2022.884034 |
Ejemplares similares
-
The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
por: Bereczki, Ilona, et al.
Publicado: (2022) -
Cross-Talking of Pathway-Specific Regulators in Glycopeptide Antibiotics (Teicoplanin and A40926) Production
por: Andreo-Vidal, Andrés, et al.
Publicado: (2023) -
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late
Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory
Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome
Coronavirus (SARS-CoV)
por: Zhou, Nan, et al.
Publicado: (2016) -
Vibrational Optical Activity Study of Four Antibiotic
(Lipo)glycopeptides: Vancomycin, Oritavancin, Dalbavancin, and Teicoplanin
por: Aerts, Roy, et al.
Publicado: (2022) -
Self-association of the glycopeptide antibiotic teicoplanin A2 in aqueous solution studied by molecular hydrodynamics
por: Chun, Taewoo, et al.
Publicado: (2023)